You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
|
|---|---|
| Published in |
Alzheimer's Research & Therapy, September 2018
|
| DOI | 10.1186/s13195-018-0425-4 |
| Pubmed ID | |
| Authors |
Emily A. Largent, Jason Karlawish, Joshua D. Grill |
| Abstract |
Global leaders have set an ambitious goal of developing interventions to effectively treat or prevent Alzheimer's disease by 2025. Achieving this goal will require clinical trials to test promising interventions, yet Alzheimer's researchers are confronting a clinical trial recruitment crisis. One reason for this is that Alzheimer's disease trials must enroll "dyads" composed of both a participant and his or her study partner. In this article, we argue that it is essential to identify ways to facilitate study partner participation, such as removing logistical barriers, offering payment, and providing paid, protected time off for study visits. Facilitating participation, particularly among non-spousal study partners, should offer a twofold benefit: faster accrual and greater generalizability of results. |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 71% |
| Sweden | 1 | 6% |
| Guinea | 1 | 6% |
| Canada | 1 | 6% |
| Switzerland | 1 | 6% |
| Unknown | 1 | 6% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 53% |
| Practitioners (doctors, other healthcare professionals) | 4 | 24% |
| Scientists | 4 | 24% |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 41 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 6 | 15% |
| Student > Ph. D. Student | 5 | 12% |
| Student > Master | 4 | 10% |
| Researcher | 4 | 10% |
| Other | 2 | 5% |
| Other | 7 | 17% |
| Unknown | 13 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 17% |
| Nursing and Health Professions | 6 | 15% |
| Social Sciences | 3 | 7% |
| Biochemistry, Genetics and Molecular Biology | 2 | 5% |
| Linguistics | 1 | 2% |
| Other | 6 | 15% |
| Unknown | 16 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2022.
All research outputs
#1,060,605
of 25,210,618 outputs
Outputs from Alzheimer's Research & Therapy
#136
of 1,436 outputs
Outputs of similar age
#22,677
of 348,090 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#4
of 35 outputs
Altmetric has tracked 25,210,618 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,436 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,090 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.